10-Q quarterly report · filed Nov 10, 2026

SANUWAVE Health, Inc. (SNWV) Q3 2026 10-Q Quarterly Report

Short answer

SANUWAVE Health, Inc. (SNWV) filed its Q3 2026 10-Q quarterly report on Nov 10, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $9M (down 25.1% year over year) with net income of −$1M.

Q3 2026 key financials · XBRL

Revenue
$9M
−25.1% YoY · −11.9% QoQ
Net income
−$1M
−113.7% YoY · −107.6% QoQ
Operating margin
-12.5%
Gross margin
77.3%
EPS (diluted)
−$0.16
−117.4% YoY · −100.0% QoQ

Source: XBRL data from the SANUWAVE Health, Inc. (SNWV) Q3 2026 10-Q on SEC EDGAR. USD.

SANUWAVE Health, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $8.6M, down 24% YoY from $11.3M
  • Gross margin 77% vs 78% YoY, operating loss $1.1M vs operating income $0.9M
  • Worst performer Ultramist® systems: $1.2M, down 73% from $4.4M
  • Cash $6.6M, operating cash outflow $29K, financing outflow $4.6M
  • Near-term headwinds: weaker capital sales, used-system availability, Nasdaq MVLS compliance by March 22, 2027

Risk Factors

  • Newly added covenant risk: JPM Credit Agreement breach as of September 30, 2026, waived under October 28 amendment
  • Reimbursement risk: CPT 97610 Medicare payment falling to $314.54 in 2027 from $397.81 in 2026
  • Regulatory risk: CMS estimates skin-substitute reimbursement changes reduce Medicare spending nearly 90%
  • Market risk: Customer reimbursement pressure contributed to deferred or reduced capital purchases during 2026
  • Nasdaq compliance risk: MVLS below $50.0 million threshold, with compliance deadline March 22, 2027

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other SANUWAVE Health, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.